209 related articles for article (PubMed ID: 34405013)
21. Expression and Prognostic Role of CXCL1 Gene in Colorectal Adenocarcinoma.
Xia C; He L; Sun Y
Comput Intell Neurosci; 2022; 2022():5504731. PubMed ID: 35958781
[TBL] [Abstract][Full Text] [Related]
22. Elevated of NDUFA4L2 expression in colon adenocarcinoma is correlated with an unfavorable prognosis and increased immune cell infiltration.
Mei Q; Chen P; Lv Y; Zheng L; Liu D; Zhang M; Liu W; Li P
Heliyon; 2024 Feb; 10(3):e25462. PubMed ID: 38352787
[TBL] [Abstract][Full Text] [Related]
23. Systematic Analysis of CXC Chemokine-Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis.
Situ Y; Lu X; Cui Y; Xu Q; Deng L; Lin H; Shao Z; Chen J
Biomed Res Int; 2022; 2022():5137301. PubMed ID: 36246978
[TBL] [Abstract][Full Text] [Related]
24. The Perspective of Diagnostic and Prognostic Values of Lipoxygenases mRNA Expression in Colon Adenocarcinoma.
Ruan GT; Gong YZ; Zhu LC; Gao F; Liao XW; Wang XK; Zhu GZ; Liao C; Wang S; Yan L; Xie HL; Zhou X; Liu JQ; Shao MN; Gan JL
Onco Targets Ther; 2020; 13():9389-9405. PubMed ID: 33061426
[TBL] [Abstract][Full Text] [Related]
25. Clinical Correlation of Wnt2 and COL8A1 With Colon Adenocarcinoma Prognosis.
Zhang L; Jiang X; Li Y; Fan Q; Li H; Jin L; Li L; Jin Y; Zhang T; Mao Y; Hua D
Front Oncol; 2020; 10():1504. PubMed ID: 32983993
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and prognostic potential of the novel biomarker nuclear cap binding protein subunit 2 (
Bu H; Cao T; Li X; Guo Y; Guo J; Wang Y; Sun Y; Wang D
J Gastrointest Oncol; 2022 Aug; 13(4):1782-1792. PubMed ID: 36092349
[TBL] [Abstract][Full Text] [Related]
27. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
28. Peroxiredoxins and Immune Infiltrations in Colon Adenocarcinoma: Their Negative Correlations and Clinical Significances, an In Silico Analysis.
Zhang X; Gao F; Li N; Zhang J; Dai L; Yang H
J Cancer; 2020; 11(11):3124-3143. PubMed ID: 32231717
[No Abstract] [Full Text] [Related]
29. Identification of the six-hormone secretion-related gene signature as a prognostic biomarker for colon adenocarcinoma.
Jia X; Zhang T; Lv X; Du H; Sun Y; Guan Y
Cancer Biomark; 2023; 38(4):523-535. PubMed ID: 38143338
[TBL] [Abstract][Full Text] [Related]
30. Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma.
Tang X; Lin Y; He J; Luo X; Liang J; Zhu X; Li T
World J Surg Oncol; 2022 Mar; 20(1):74. PubMed ID: 35264195
[TBL] [Abstract][Full Text] [Related]
31. Prognostic and Predicted Significance of FENDRR in Colon and Rectum Adenocarcinoma.
Yang F; Sun S; Yang F
Front Oncol; 2021; 11():668595. PubMed ID: 34621665
[TBL] [Abstract][Full Text] [Related]
32. Downregulated ARID1A by miR-185 Is Associated With Poor Prognosis and Adverse Outcomes in Colon Adenocarcinoma.
Baldi S; Khamgan H; Qian Y; Wu H; Zhang Z; Zhang M; Gao Y; Safi M; Al-Radhi M; Zuo YF
Front Oncol; 2021; 11():679334. PubMed ID: 34414106
[TBL] [Abstract][Full Text] [Related]
33. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Huang W; Liu Z; Li Y; Liu L; Mai G
J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
[TBL] [Abstract][Full Text] [Related]
34. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of PD-L1 predicts poor prognosis and is associated with miR-191-5p dysregulation in colon adenocarcinoma.
Chen XY; Zhang J; Hou LD; Zhang R; Chen W; Fan HN; Huang YX; Liu H; Zhu JS
Int J Immunopathol Pharmacol; 2018; 32():2058738418790318. PubMed ID: 30045644
[TBL] [Abstract][Full Text] [Related]
36. Systematic analysis of the function and prognostic value of RNA binding proteins in Colon Adenocarcinoma.
Qi X; Liu Z; Zhang Q; Yang M; Wan Y; Huang J; Xu L
J Cancer; 2021; 12(9):2537-2549. PubMed ID: 33854615
[No Abstract] [Full Text] [Related]
37. Integrated multiplex network based approach reveled CC and CXC chemokines associated key biomarkers in colon adenocarcinoma patients.
Huang W; Hu Y; Zhang X; Xu Y; Sun Z; Ding P; Qian X; Ali A; Chen Z
Am J Cancer Res; 2023; 13(11):5531-5548. PubMed ID: 38058831
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and prognostic values of C‑X‑C motif chemokine ligand 3 in patients with colon cancer.
Ruan GT; Gong YZ; Liao XW; Wang S; Huang W; Wang XK; Zhu GZ; Liao C; Gao F
Oncol Rep; 2019 Nov; 42(5):1996-2008. PubMed ID: 31545503
[TBL] [Abstract][Full Text] [Related]
39. Gene Expression Profiling of Tricarboxylic Acid Cycle and One Carbon Metabolism Related Genes for Prognostic Risk Signature of Colon Carcinoma.
Zhang Z; Zhu H; Li Q; Gao W; Zang D; Su W; Yang R; Zhong J
Front Genet; 2021; 12():647152. PubMed ID: 34589110
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide RNA-sequencing dataset reveals
Liao C; Gu Z; Huang W; Gong Y; Liao X; Lin M; Zhang S
J Cancer; 2023; 14(12):2386-2398. PubMed ID: 37576398
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
